Guidant Likely Will Bow Out Of AAA Race As Stakes Rise Too High

Guidant is poised to exit the abdominal aortic aneurysm market, which could eventually reach $1 bil., citing declining sales and a lack of adoption by vascular surgeons of its Ancure AAA endovascular stent graft